- Home
- BSX vs RMBS Comparison
BSX vs RMBS Comparison
Compare BSX & RMBS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BSX
- RMBS
- Stock Information
- Founded
- BSX 1979
- RMBS 1990
- Country
- BSX United States
- RMBS United States
- Employees
- BSX N/A
- RMBS N/A
- Industry
- BSX Medical/Dental Instruments
- RMBS Semiconductors
- Sector
- BSX Health Care
- RMBS Technology
- Exchange
- BSX Nasdaq
- RMBS Nasdaq
- Market Cap
- BSX 138.4B
- RMBS N/A
- IPO Year
- BSX 1992
- RMBS 1997
- Fundamental
- Price
- BSX $104.49
- RMBS $63.48
- Analyst Decision
- BSX Strong Buy
- RMBS Strong Buy
- Analyst Count
- BSX 22
- RMBS 4
- Target Price
- BSX $112.86
- RMBS $78.25
- AVG Volume (30 Days)
- BSX 7.5M
- RMBS 856.8K
- Earning Date
- BSX 07-23-2025
- RMBS 07-28-2025
- Dividend Yield
- BSX N/A
- RMBS N/A
- EPS Growth
- BSX 15.23
- RMBS N/A
- EPS
- BSX 1.37
- RMBS 1.91
- Revenue
- BSX $17,554,000,000.00
- RMBS $605,417,000.00
- Revenue This Year
- BSX $17.50
- RMBS $26.07
- Revenue Next Year
- BSX $10.75
- RMBS $12.64
- P/E Ratio
- BSX $75.30
- RMBS $33.52
- Revenue Growth
- BSX 19.36
- RMBS 30.13
- 52 Week Low
- BSX $71.88
- RMBS $37.43
- 52 Week High
- BSX $107.53
- RMBS $69.15
- Technical
- Relative Strength Index (RSI)
- BSX 49.67
- RMBS 61.90
- Support Level
- BSX $101.56
- RMBS $63.55
- Resistance Level
- BSX $104.41
- RMBS $65.76
- Average True Range (ATR)
- BSX 1.83
- RMBS 1.69
- MACD
- BSX -0.11
- RMBS -0.12
- Stochastic Oscillator
- BSX 34.54
- RMBS 73.87
About BSX Boston Scientific Corporation
Boston Scientific produces less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, kidney stone management, cardiac rhythm management, catheter-directed ultrasound imaging, upper gastrointestinal tract diagnostics, interventional oncology, neuromodulation for chronic pain, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for nearly half of the firm's total sales.